<?xml version="1.0" encoding="UTF-8"?>
<p>Survival differences were not explained by NIH-Severity alone. When NIH-Severity was viewed on the viSNE scatter plot, clusters varied in NIH-Severity. For example, Cluster 2 patients had a combination of moderate and severe chronic GvHD (
 <xref ref-type="fig" rid="f1-1040189">Figure 1</xref>). Additionally, when overall survival of all patients was stratified by NIH-Severity in a Kaplan-Meier analysis, NIH-Severity did not significantly stratify overall survival (log-rank for trend: 
 <italic>P</italic>=0.08) (
 <italic>Online Supplementary Figure S6</italic>).
</p>
